B17. Executing Without Boundaries
Tracks
Reimbursement/Market Access
Wednesday, June 4, 2025 |
2:45 PM - 3:45 PM |
C2.4 |
Chair & Speakers
Mr Paul Cross
Managing Director And Publisher
Daily Dispatch
B17. Executing Without Boundaries
Abstract
In a policy and media landscape that has never been more fragmented, executing strategy without traditional boundaries has become both a necessity and a competitive advantage. In this session, Paul Cross, founder of BioPharmaDispatch and BiotechDispatch, draws on over two decades of experience in government, industry, and media to challenge how healthcare leaders think about communication, policy engagement, and decision-making in complex systems.
From the politics of the PBS to the rise of digital discourse in health, Paul will explore how the pharmaceutical and biotech sectors can better anticipate risk, shape public narrative, and deliver outcomes in a world where influence and expectations are shifting. The language is what matters and, at the moment, the language is not connecting to the realities or the actions demanded by so many stakeholders.
Whether you work in regulatory affairs, market access, corporate strategy or advocacy, this session will equip you with sharp insights into cutting through noise, driving momentum, and leading when the playbook changes.
From the politics of the PBS to the rise of digital discourse in health, Paul will explore how the pharmaceutical and biotech sectors can better anticipate risk, shape public narrative, and deliver outcomes in a world where influence and expectations are shifting. The language is what matters and, at the moment, the language is not connecting to the realities or the actions demanded by so many stakeholders.
Whether you work in regulatory affairs, market access, corporate strategy or advocacy, this session will equip you with sharp insights into cutting through noise, driving momentum, and leading when the playbook changes.
Biography
Paul Cross is the Managing Director and Publisher at Daily Dispatch, the company responsible for BioPharmaDispatch and BiotechDispatch. He is a business owner and founder, a former ministerial adviser to two Australian health ministers, and a pharmaceutical industry executive in Australia and the US.
